Nicholas Stucky, MD, PhD

Truveta, Inc.

Poster(s):

• (031) Real-World Patterns in Treatment Switching to Biosimilar Adalimumab in the United States
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (097) Real-World Patterns in GLP-1 RA Switching from 2018-2023 in the US
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST

• (162) Decreased Hazard of Potassium Lowering Drug Prescription Receipt Following Implementation of the 2021 CKD-EPI Creatinine GFR Equation
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST